Ashraf Ul Kabir

448 citations
13 papers · 305 indexed · h-index 8
Topics
Immune cells in cancer (4 papers)Angiogenesis and VEGF in Cancer (4 papers)Natural Antidiabetic Agents Studies (3 papers)

In The Last Decade

Ashraf Ul Kabir

13 papers receiving 301 citations

Peers

Ashraf Ul Kabir
Comparison fields: 5 of 73
  • Molecular Biology 111
  • Pharmacology 64
  • Complementary and alternative medicine 63
  • Endocrinology, Diabetes and Metabolism 62
  • Immunology 44
Replace Hyun‐Kyoung Kim with:
Hyun‐Kyoung Kim South Korea
Xichao Yu China
Bo‐Ram Jin South Korea
Xiangchun Shen China
Shu Dai China
Chan Wu China
Hala E. Abdel‐Hamied Egypt
Tae‐Hyeon Kim South Korea
Hsiao‐Ting Wu Taiwan
Kyoung Jin Nho South Korea
Ashraf Ul Kabir relative to Hyun‐Kyoung Kim South Korea Hyun‐Kyoung Kim's profile →
Citations per field
00.5×
Hyun‐Kyoung Kim · 1×
Citations per year

Countries citing papers authored by Ashraf Ul Kabir

Since Specialization
Citations

This map shows the geographic impact of Ashraf Ul Kabir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashraf Ul Kabir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashraf Ul Kabir more than expected).

Fields of papers citing papers by Ashraf Ul Kabir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashraf Ul Kabir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashraf Ul Kabir. The network helps show where Ashraf Ul Kabir may publish in the future.

Co-authorship network of co-authors of Ashraf Ul Kabir

This figure shows the co-authorship network connecting the top 25 collaborators of Ashraf Ul Kabir. A scholar is included among the top collaborators of Ashraf Ul Kabir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashraf Ul Kabir. Ashraf Ul Kabir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 5
2 7
3 1
4 19
5 6
6 53
7 18
8 21
9 85
10 4
11 17
12 6
13 63

About Ashraf Ul Kabir

Ashraf Ul Kabir is a scholar working on Endocrinology, Diabetes and Metabolism, Immunology and Biochemistry, having authored 13 papers that have together received 305 indexed citations. Recurring topics across this work include Immune cells in cancer (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Natural Antidiabetic Agents Studies (3 papers). The work is most often cited by research in Complementary and alternative medicine (63 citations), Pharmacology (64 citations) and Endocrinology, Diabetes and Metabolism (62 citations). Ashraf Ul Kabir has collaborated with scholars based in United States, Bangladesh and South Korea. Frequent co-authors include J. M. A. Hannan, Kyunghee Choi, Ahmed Arif, Karen Krchma, Samuel A. Wickline, Craig S. Smith, Hua Pan, Sunday S. Oladipupo, Jun Wu and David M. Ornitz. Their work appears in journals such as Nature reviews. Immunology, Nature Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026